|
AP4E1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.013200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.964630E-01 |
| Normal-vs-Stage2 |
1.732430E-01 |
| Normal-vs-Stage3 |
8.151800E-02 |
| Normal-vs-Stage4 |
2.601600E-01 |
| Stage1-vs-Stage2 |
5.152200E-01 |
| Stage1-vs-Stage3 |
3.310000E-01 |
| Stage1-vs-Stage4 |
8.434400E-01 |
| Stage2-vs-Stage3 |
9.599800E-01 |
| Stage2-vs-Stage4 |
6.450000E-01 |
| Stage3-vs-Stage4 |
5.838600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.091840E-01 |
| Normal-vs-AfricanAmerican |
5.926000E-02 |
| Normal-vs-Asian |
2.209400E-01 |
| Caucasian-vs-AfricanAmerican |
3.057600E-01 |
| Caucasian-vs-Asian |
4.390300E-02 |
| AfricanAmerican-vs-Asian |
2.002400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.616400E-02 |
| Normal-vs-Female |
3.795800E-01 |
| Male-vs-Female |
1.440580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.094000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.320200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.428200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.016000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.521400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.436800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.625600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.442200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.410400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.061200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.443800E-01 |
| Normal-vs-Grade 2 |
4.021400E-01 |
| Normal-vs-Grade 3 |
4.653600E-02 |
| Normal-vs-Grade 4 |
1.995380E-01 |
| Grade 1-vs-Grade 2 |
8.269400E-01 |
| Grade 1-vs-Grade 3 |
3.339400E-01 |
| Grade 1-vs-Grade 4 |
5.550400E-01 |
| Grade 2-vs-Grade 3 |
8.910100E-02 |
| Grade 2-vs-Grade 4 |
4.970400E-01 |
| Grade 3-vs-Grade 4 |
5.247200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.284250E-01 |
| Normal-vs-ccB subtype |
5.926200E-01 |
| ccA subtype-vs-ccB subtype |
2.194600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.571600E-01 |
| Normal-vs-N1 |
9.414000E-01 |
| N0-vs-N1 |
4.975200E-01 |
|
|
